Gene expression pattern contributing to prognostic factors in childhood acute lymphoblastic leukemia

References

• Pui CH, Carroll WL, Meshinchi S, . Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011;29:551–565.
   PubMed Web of Science ®Google Scholar
• Evans WE, Relling MV. Moving towards individualized medicine with pharmacogenomics. Nature 2004;27:464–468.
   Web of Science ®Google Scholar
• Kaspers GJL, Veerman AJP, Pieters R, . In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997;90:2723–2729.
   PubMed Web of Science ®Google Scholar
• Flotho C, Coustan-Smith E, Pei D, . A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood 2007;15:1271–1277.
   Web of Science ®Google Scholar
• Schmiegelow K, Nyvold C, Seyfarth J, . Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance. Leukemia 2001;15:1066–1071.
   PubMed Web of Science ®Google Scholar
• da Silva Silveira V, Canalle R, Scrideli CA, . Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia. Leuk Res 2009;33: 898–901.
   PubMed Web of Science ®Google Scholar
• Flohr T, Schrauder A, Cazzaniga G, . Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008;22:771–782.
   PubMed Web of Science ®Google Scholar
• Yeoh EJ, Ross ME, Shurtleff SA, . Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133–143.
   PubMed Web of Science ®Google Scholar
• Holleman A, Cheok MH, den Boer ML, . Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 2004;351:533–542.
   PubMed Web of Science ®Google Scholar
• Scrideli CA, Assumpção JG, Ganazza MA, . A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups. Haematologica 2009;94:781–789.
   PubMed Web of Science ®Google Scholar
• Brandalise SR, Pinheiro VR, Aguiar SS, . Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99. J Clin Oncol 2010;28:1911–1918.
   PubMed Web of Science ®Google Scholar
• Brandalise SR. Prognostic value of day 8 peripheral blood response for children with acute lymphocytic leukemia. In Zander AR, editor. Gene technology: stem cell and leukemia research. Berlin: Spring-Verlag; 1996. pp. 421–428.
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Methods2001;25:402–408.
   Google Scholar
• Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 2006;354:166–178.
   PubMed Web of Science ®Google Scholar
• Lugthart S, Cheok MH, den Boer ML, . Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 2005;7: 375–386.
   PubMed Web of Science ®Google Scholar
• Holleman A, den Boer ML, de Menezes RX, . The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia. Blood 2006;107:769–776.
   PubMed Web of Science ®Google Scholar
• Sorich MJ, Pottier N, Pei D, . In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoS Med 2008;5:e83.
   Web of Science ®Google Scholar
• De Pittà C, Tombolan L, Campo Dell’Orto M, . A leukemia-enriched cDNA microarray platform identifies new transcripts with relevance to the biology of pediatric acute lymphoblastic leukemia. Haematologica 2005;90:890–898.
   PubMed Web of Science ®Google Scholar
• Cario G, Fetz A, Bretscher C, . Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia. Ann Hematol 2008;87:709–716.
   Google Scholar
• Andersson CR, Lindgren D, Edén P, . Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status array-based classification of pediatric AML and ALL. Leukemia 1997;21:1198–1203.
   Web of Science ®Google Scholar
• Kirschner-Schwabe R, Lottaz C, Todling J, . Expression of late cell cycle genes and an increased proliferative capacity characterize very early relapse of childhood acute lymphoblastic leukemia. Clin Cancer Res 2006;12:4553–4561.
   PubMed Web of Science ®Google Scholar
• Selfors LM, Schutzman JL, Borland CZ, . Soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling. Proc Natl Acad Sci USA 1998;95:6903–6908.
   PubMed Web of Science ®Google Scholar
• Sieburth DS, Sun Q, Han M. SUR-8, a conserved Ras-binding protein with leucine-rich repeats, positively regulates Ras-mediated signaling in C. elegans. Cell 1998;94:119–130.
   PubMed Web of Science ®Google Scholar
• Li W, Han M, Guan KL. The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev 2000;14:895–900.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, . A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. Mol Cell 2006;22:217–230.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9:180–186.
   PubMed Web of Science ®Google Scholar
• Huang YZ, Zang M, Xiong WC, . Erbin suppresses the MAP kinase pathway. J Biol Chem 2003;278:1108–1114.
   PubMed Web of Science ®Google Scholar
• Pui CH, Relling MV, Downing JR. Acute lymphoblastic leukemia. N Engl J Med 2004;350:1535–1548.
   PubMed Web of Science ®Google Scholar
• Conter V, Bartram CR, Valsecchi MG, . Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010;115:3206–3214.
   PubMed Web of Science ®Google Scholar
• Bhojwani D, Kang H, Menezes RX, .; Children's Oncology Group Study; Dutch Childhood Oncology Group; German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: a Children's Oncology Group Study [corrected]. J Clin Oncol 2008;26:4376–4384. Erratum in J Clin Oncol 2008;26:5142.
   PubMed Web of Science ®Google Scholar